BBVA
ALNY icon

Banco Bilbao Vizcaya Argentaria’s Alnylam Pharmaceuticals ALNY Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,926
Closed -$8.72M – 727
2025
Q4 		$8.72M Sell
21,926
-309
-1% -$137K 0.06% 227
2025
Q3 		$10.1M Sell
22,235
-16
-0.1% -$6.51K 0.08% 195
2025
Q2 		$7.26M Sell
22,251
-512
-2% -$142K 0.07% 219
2025
Q1 		$6.15M Buy
22,763
+609
+3% +$157K 0.06% 237
2024
Q4 		$5.21M Buy
22,154
+413
+2% +$109K 0.05% 257
2024
Q3 		$5.98M Buy
+21,741
New +$5.66M 0.06% 245

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's ALNY Position: Q1 2026 in Review

Banco Bilbao Vizcaya Argentaria sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2026, closing a stake of 21,926 shares — an estimated $8.72M sold.

Banco Bilbao Vizcaya Argentaria first reported a position in ALNY in Q3 2024 and held it in 6 quarters. The position peaked at $10.1M in Q3 2025. 791 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Alnylam Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 21,926 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $8.72M.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Alnylam Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • Banco Bilbao Vizcaya Argentaria's Alnylam Pharmaceuticals position peaked at $10.1M in Q3 2025.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2026, filed 14 May 2026.